Drug Discovery and Design: Focus on computational approaches used in the discovery and design of new drugs

Abstract

Computational approaches have revolutionized the field of drug discovery and design, offering efficient and cost-effective strategies for identifying and developing new therapeutics. This review article explores the application of computational methods in drug discovery, with a focus on virtual screening techniques, molecular docking, molecular dynamics simulations, and quantitative structure-activity relationship (QSAR) models. Virtual screening plays a crucial role in narrowing down large chemical libraries by utilizing ligand-based and structure-based approaches. Ligand-based methods, such as pharmacophore modeling and QSAR analysis, exploit the knowledge of known ligand structures and their activity data to predict potential drug candidates. Structure-based methods, such as molecular docking and fragment-based drug design, enable the identification of small molecules that bind tightly to target proteins through intricate molecular interactions. Molecular docking employs algorithms to predict the binding modes and affinities of small molecules with target proteins, aiding in the identification of promising drug candidates. Additionally, molecular dynamics simulations provide insights into the dynamic behavior of protein-ligand complexes, enabling the exploration of conformational changes and the evaluation of binding stability over time. QSAR models, on the other hand, establish quantitative relationships between the chemical structures of compounds and their biological activities, allowing for the prediction of the activity of untested molecules. Recent advancements in machine learning and deep learning techniques have further enhanced the predictive power and accuracy of QSAR models, contributing to efficient drug discovery efforts.

This review article highlights notable successes in using computational methods for drug development, including the discovery of novel drugs through virtual screening, the design of potent inhibitors via molecular docking, the exploration of binding kinetics using molecular dynamics simulations, and the prediction of compound activities using QSAR models.